Targeted chemotherapy represents a significant advancement in cancer treatment, offering a more precise and less harmful approach compared to traditional chemotherapy. This method involves delivering chemotherapy drugs directly to cancer cells, sparing healthy tissue from damage and reducing side effects. Through innovative techniques such as monoclonal antibodies and nanoparticles, researchers can specifically target cancer cells based on their unique characteristics, such as surface proteins or genetic mutations. By honing in on these specific targets, targeted chemotherapy not only enhances treatment efficacy but also minimizes collateral damage to the body. This tailored approach holds promise for improving patient outcomes and quality of life, ushering in a new era of precision medicine in cancer care.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States